Published 7 hours ago • loading... • Updated 6 hours ago
'Exciting' milestone as weight loss pills hit shelves
The approvals could widen access as doctors expect demand to surge and the federal government weighs a PBS subsidy that could cut monthly costs to $25.
On Friday, Australian pharmacies began stocking Wegovy, the first weight-loss pill approved by the Therapeutic Goods Administration , offering patients a daily alternative to weekly injections.
Previously restricted to weekly injections, GLP-1 medications now include daily oral tablets as manufacturers Novo Nordisk and Eli Lilly compete to expand access to weight-loss treatments.
Patients face costs between $250 and $370 per month depending on dosage; teacher Kim Roberts, a mother-of-six, said the daily pill "will just fit in with what I do on a day-to-day basis."
Federal government negotiations to list Wegovy on the Pharmaceutical Benefits Scheme could reduce costs to $25 per script, though current pricing is already driving consumer demand for protein-rich foods.
Professor Jason Kovacic of the Victor Chang Cardiac Research Institute called the drugs "exciting" for cardiovascular risk management, though experts warn that without professional monitoring, users face potential malnutrition and long-term health risks.